The Recombinant Therapeutic Antibodies and Proteins industry is rapidly evolving, driven by innovative biotechnological advancements catering to chronic diseases and personalized medicine. Demand for highly specific and effective biologics continues to push market revenue and propel strategic developments globally. https://hallbook.com.br/blogs/802113/Recombinant-Therapeutic-Antibodies-And-Proteins-Market-Growth-Driven-by-Innovation